Improving Healthcare Access and Safety through an APAC Medical Platform
First written in FY2023-Q2. 6 of 7 entries say "Restated". Latest entry: FY2026.
1 other company's latest entry also says "Restated".
- FY2026RestatedAnnual report
「The Group supports the marketing activities of healthcare-related businesses, including pharmaceutical companies worldwide, by utilizing its membership base of healthcare professionals in APAC countries.」
The policy of promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country, and supporting marketing activities by utilizing the membership base, is being reconfirmed. - FY2025RestatedAnnual report
「The Group supports the marketing activities of healthcare-related businesses, including pharmaceutical companies worldwide, by utilizing its membership base of healthcare professionals in APAC countries.」
The policy of promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country, and supporting marketing activities by utilizing the membership base, is being reconfirmed. - FY2024-Q3RestatedAnnual report
「Going forward, the Group will maximize the value it provides as a medical platform and achieve sustainable long-term growth by expanding the industries and business types served, increasing the number of customers, expanding the types and volume of information provided while improving its quality, expanding and activating its membership base of healthcare professionals, and analyzing and utilizing accumulated information.」
The growth strategy for medical platforms optimized for each APAC country, involving the expansion and utilization of the service recipients, customers, information, healthcare-professional membership base and accumulated information, is being reconfirmed. - FY2024-Q1RestatedAnnual report
「In the overseas field, specifically the medical platform business, the APAC region faces the social challenge that “the availability of pharmaceuticals, medical devices and other products is relatively delayed, and the quality of healthcare is inadequate.” The Group seeks to address this by promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country that connect healthcare-related businesses and other providers with healthcare professionals.」
The direction of promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country is being reconfirmed. - FY2023RestatedAnnual report
「In the overseas field, specifically the medical platform business, the APAC region faces the social challenge that “the availability of pharmaceuticals, medical devices and other products is relatively delayed, and the quality of healthcare is inadequate.” The Group seeks to address this by promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country that connect healthcare-related businesses and other providers with healthcare professionals.」
The direction of promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country is being reconfirmed. - FY2023-Q3RestatedAnnual report
「In the overseas field, specifically the medical platform business, the APAC region faces the social challenge that “the availability of pharmaceuticals, medical devices and other products is relatively delayed, and the quality of healthcare is inadequate.” The Group seeks to address this by promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country that connect healthcare-related businesses and other providers with healthcare professionals.」
The direction of promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country is being reconfirmed. - FY2023-Q2First statedAnnual report
「In the overseas field, specifically the medical platform business, the APAC region faces the social challenge that “the availability of pharmaceuticals, medical devices and other products is relatively delayed, and the quality of healthcare is inadequate.” The Group seeks to address this by promoting the expansion of access to healthcare and improvements in safety through medical platforms optimized for each APAC country that connect healthcare-related businesses and other providers with healthcare professionals.」
For the delayed availability of pharmaceuticals and medical devices and the challenges involving healthcare quality in APAC, the direction of building medical platforms optimized for each country to promote the expansion of access to healthcare and improvements in safety is being stated for the first time.